Last reviewed · How we verify
Placebo Ophthalmic Solution — Competitive Intelligence Brief
phase 3
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo Ophthalmic Solution (Placebo Ophthalmic Solution) — ORA, Inc.. This is a placebo ophthalmic solution, meaning it has no active therapeutic effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo Ophthalmic Solution TARGET | Placebo Ophthalmic Solution | ORA, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo Ophthalmic Solution CI watch — RSS
- Placebo Ophthalmic Solution CI watch — Atom
- Placebo Ophthalmic Solution CI watch — JSON
- Placebo Ophthalmic Solution alone — RSS
Cite this brief
Drug Landscape (2026). Placebo Ophthalmic Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-ophthalmic-solution. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing